CMS advises PINOVA on its investment in Ideal-tek in Switzerland

Frankfurt am Main – The funds managed by PINOVA Capital GmbH (PINOVA) have acquired a stake in Ideal-tek SA, which is based in Balerna (Canton of Ticino, Switzerland). With this transaction, the leading Swiss manufacturer of high-precision tools gains an experienced partner for its next phase of growth.

An international CMS team led by Dr Peter Polke (Germany) and Dr Daniel Jenny (Switzerland) provided PINOVA with comprehensive legal advice on this transaction. PINOVA has been a CMS client for many years.

For more than 60 years, Ideal-tek has been developing and manufacturing high-precision tweezers, pliers and cutting tools, which are used in sectors including medical technology, the aerospace and defence industries, electronics manufacturing, life sciences and the watch industry. This is complemented by a production site in Italy and a sales company in the USA. Customers in 45 countries are supplied through a network of around 150 distribution partners. PINOVA's investment is intended, in particular, to further drive the company's international expansion.

PINOVA is an independent private equity firm that invests its managed funds in industrial tech companies in the DACH region. The focus is on companies in the fields of high-tech components, innovative materials and smart systems. With its investment in Ideal-tek, PINOVA adds a highly profitable niche market leader whose mission-critical products are deeply integrated into customers' value chains and which offers strong international growth potential, particularly in North America, as well as opportunities for targeted acquisitions.

Press Contact
presse@cms-hs.com